Tianjin Lisheng Pharmaceutical Co.,Ltd. engages in the research and development, production, and sale of pharmaceutical products in China. It offers its products in various forms comprising tablets, soft capsules, granules, flat films, pills, mixture, and injection for use in various therapeutic fields, such as nervous system, musculoskeletal, genitourinary system, antineoplastic and immune system, sensory system, systemic anti-infection, respiratory system, endocrine system, digestive system, and cardiovascular system, as well as drugs for invigorating qi and blood. The company also provides Chinese and Western tablets, capsules, oral liquids, granules, biological agents, and APIs. It also exports its products. The company was founded in 1951 and is based in Tianjin, China. Tianjin Lisheng Pharmaceutical Co.,Ltd. operates as a subsidiary of Tianjin Jinhao Pharmaceutical Co., Ltd.
Metrics to compare | 002393 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship002393PeersSector | |
---|---|---|---|---|
P/E Ratio | 27.6x | 28.0x | −0.5x | |
PEG Ratio | −0.53 | −0.95 | 0.00 | |
Price/Book | 1.0x | 2.9x | 2.6x | |
Price / LTM Sales | 3.7x | 4.1x | 3.2x | |
Upside (Analyst Target) | - | 16.2% | 45.9% | |
Fair Value Upside | Unlock | 10.5% | 7.0% | Unlock |